06 April 2018

Director/PDMR Dealing

The Company today announces that on 5 April 2018, Hilary Spence, Chief Financial Officer ("CFO") of the Company, was granted options (the "Options") over 2,000,000 ordinary shares of 1 pence each in the share capital of the Company ("Shares") exercisable at a price of 2.70 pence per Share.

The Options, will vest in three equal tranches on the first, second and third anniversaries of 3 January 2018, being the date of Ms. Spence's appointment as CFO. Such vesting will be conditional on her continued employment.  In addition, the ability to exercise any vested Options will be dependent on achieving a closing middle market price per Share of 10 pence at any time after the date of grant and on the Company delivering sustainable positive cash flows from operations for any period of six months. All Options will lapse after 10 years from the date of grant, being 5 April 2018.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Hilary Spence
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification / Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Collagen Solutions Plc
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p each

ISIN Code: GB00B94T6Y14
b) Nature of the transaction Grant of options over ordinary shares of 1p each exercisable at 2.70p per share
c) Price(s) and volume(s)
Price(s) Volume(s)
2.70 pence 2,000,000
d) Aggregated information
- Aggregated volume
- Price

e) Date of the transaction 05/04/2018
f) Place of the transaction Outside a trading venue



Collagen Solutions Plc
Jamal Rushdy, Chief Executive Officer
Hilary Spence, Chief Financial Officer
Tel: +44 (0) 141 648 9100
Lisa Baderoon, Head of Investor Relations Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com
Cenkos Securities plc (Nominated Adviser and Broker)
Stephen Keys
Steve Cox
Tel: 0207 397 8900
Walbrook PR
Anna Dunphy
Helen Cresswell
Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.com
Mob: +44 (0) 7876 741 001